Triple Agonist 60mg — Verification Report
From Peptide RUO LLC · Lot RT600421 · Tested May 2026
VialTalk
Triple Agonist 60mg
Peptide RUO LLC
Score
92.6
Grade
A
Excellent
Lot RT600421
Tested May 2026
Report ID
a60bf16b
Test
Method
Result
Status
PurityFull credit
HPLC
99.96%
Full credit
IdentityFull credit
Mass spectrometry
Confirmed
Full credit
ContentFull credit
Gravimetric vs label claim
60 mg labeled · 62.34 mg tested
Full credit
EndotoxinNot submitted
Not tested
Not tested
Not submitted
Heavy metalsNot submitted
Not tested
Not tested
Not submitted
SterilityNot submitted
Not tested
Not tested
Not submitted
Batch conformityNot submitted
Not tested
Not tested
Not submitted
Verified against the submitted certificate. VialTalk received this vendor's certificate, checked each test against the reported method, and scored it under a published methodology. Tests the vendor did not submit are listed above rather than omitted.
This report is issued by VialTalk. It is not a laboratory certificate.Scoring methodology →
Canonical source: https://vialtalk.com/vendors/peptide-ruo-llc/coas/a60bf16b-7331-4ece-b1ac-aa10c0cede67
